Studies have indicated that EHH can inhibit NF‐κB activity and reduce the expression of TNFα‐induced matrix metalloproteinase (MMP)‐9 mRNA, thereby attenuating the migratory capabilities of breast cancer cells.6 Here, NFKB1 is linked to breast carcinoma.